Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention. - Wikidata - awgldk - TriplyDB

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

http://www.wikidata.org/entity/Q37497555

about

Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implications Platelet function tests: a review of progresses in clinical application The interaction between preoperative platelet count and function and its relationship with postoperative bleeding in cardiac surgery.Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.Antithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients.The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial.High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction.Impact of aspirin dosing on the effects of P2Y12 inhibition in patients with acute coronary syndromes.Contemporary antiplatelet therapy in patients undergoing percutaneous coronary intervention.Front-loading with clopidogrel plus aspirin followed by dual antiplatelet therapy in the prevention of early stroke recurrence.Novel antiplatelet agents in acute coronary syndrome.Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy.Impact of tailored anti-P2Y12 therapies in acute coronary syndromes.P2Y12 antagonists in non-ST-segment elevation acute coronary syndromes: latest evidence and optimal use Development of a concept for a personalized approach in the perioperative antiplatelet therapy administration/discontinuation management based on multiple electrode aggregometry in patients undergoing coronary artery surgery.Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study.Platelet function testing as a biomarker for efficacy of antiplatelet drugs.Assessment of platelet function in patients receiving tirofiban early after primary coronary intervention.Serial clopidogrel dose adjustment after platelet function testing improves outcome of acute coronary syndrome patients undergoing percutaneous coronary intervention with high on-treatment platelet reactivity.Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.Platelet Function Testing-Guided Antiplatelet Therapy Impact of the bioresorbable vascular scaffold surface area on on-treatment platelet reactivity.Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow.Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.Prior exposure to aspirin in acute coronary syndrome patients: a cardiovascular risk marker or a predictor of adverse outcome? A contemporary data of a national registry.Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays.Accumetrics-based clopidogrel dosing in endovascular neurosurgery.Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention.Antiplatelet Therapy in ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors.Platelet Testing is Associated with Worse Clinical Outcomes for Patients Treated with the Pipeline Embolization Device.Antiplatelet Therapy Changes for Patients With Myocardial Infarction With Recurrent Ischemic Events: Insights Into Contemporary Practice From the TRANSLATE-ACS (Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns an Impact of Test Conditions on ADP-Induced Platelet Function Results With the Multiplate Assay: Is Further Standardization Required?MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers?Validation of a New ELISA-Based Vasodilator-Associated Stimulated Phosphoprotein Phosphorylation Assay to Assess Platelet Reactivity Index in a Chinese Population.Comparison of pharmacodynamics between low dose ticagrelor and clopidogrel after loading and maintenance doses in healthy Korean subjects.Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis.

P2860

Q26771106-559BF6D9-D9F3-4D79-A5D2-C99991546E80 Q26823775-1993CC3F-2F53-4497-8418-B429D8B92996 Q33439973-C2876B24-B9EA-4CDC-9203-447F8826134E Q33804996-2E812C25-27C6-4F41-8FF3-1E3741012AF0 Q34439089-A295DD1E-0A7F-4A87-9CB6-437E7266271B Q35111496-75BFE947-3A4D-4EE0-80BC-B1838C53C8DF Q36328226-60A9F53C-15A5-4CBB-BA48-FE78204BDAA7 Q36737718-70659C80-1D7C-4349-A606-AB5F44719878 Q37680302-44CD5C7C-EFC9-4FDB-9A10-B9E4877D6DEF Q38169058-BF867392-E4E3-48F1-84A7-217E55DDDE94 Q38197732-247D5872-324F-4DFE-9264-A9E6655681F4 Q38216499-C4A093A6-BD3E-49E3-8009-C0FBD6B63FBE Q38257119-D307CF1C-7006-421F-B55B-2E730B9CD79A Q38366950-DF60E768-493A-431A-BD14-9A006FD444FB Q38444425-5A1D53F5-346C-40B5-A1D1-394F1D229FB9 Q38542096-DB42416D-3EAD-4E4B-A0D4-DED04ABA5544 Q38542821-9BFAD711-646F-495B-86E5-D9F47B540C73 Q38818086-F3F0C032-9F4C-428A-BC90-2D5AB8625709 Q38842001-70EF66BD-1238-4195-ACD3-41703400DA5A Q39127444-C5F43E8D-8AED-4BF3-9A2F-6A5EA48D6CF3 Q39187857-CC826482-1136-4821-8A5E-54C84DB4D757 Q39208503-FA509CB4-2447-430F-9E1A-95FE487EFC85 Q39341052-7E4BB8AC-3435-44B8-AED9-18E53D16661A Q39949483-9A96A9A5-C8FF-4875-9A3E-B5016AA02511 Q39962890-BE3F3F21-36DE-443E-B5D4-CF86DA54E68A Q41628351-FD16379D-0FE1-4AFC-8943-E6982A2F5E21 Q42375730-FA62AF5F-B5E3-480D-90B7-6252945BE138 Q47261452-2C721E41-BE0C-46F8-A2F5-9AC3A0711628 Q47834734-F79FCB19-979D-41DE-AA17-A337E4949DC3 Q48013353-090C0E6A-089F-4530-99FE-5525F515F30F Q48316634-A8A2BF76-15E1-4F29-870E-454BC198E975 Q48507719-BACAB2C4-FBBA-47FE-9C59-5101AF69A1AB Q48964241-2929833B-5212-469C-B3BF-88D43FD8CC16 Q50044401-AC550969-11D9-4982-B293-2389DC6A599B Q50073758-BAB1809E-1E26-400C-BB65-55A46C36B206 Q50101441-77C1F674-D695-477C-9FC1-C2B6B4EB80EA Q50940673-ED083362-6DC5-499B-9924-B5091CE305C6 Q53257151-1E5080C2-1E8C-4D63-B2F5-8570092CAE62 Q53523898-983991A3-6BC5-4178-8BFE-65F589A9650A Q53765716-E4138261-72A5-40AD-A8F5-45D41809B7D1

P2860

Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention.

http://www.wikidata.org/entity/Q37497555

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Expert position paper on the r ...... taneous coronary intervention.

@en

Expert position paper on the r ...... taneous coronary intervention.

@nl

type

label

Expert position paper on the r ...... taneous coronary intervention.

@en

Expert position paper on the r ...... taneous coronary intervention.

@nl

prefLabel

Expert position paper on the r ...... taneous coronary intervention.

@en

Expert position paper on the r ...... taneous coronary intervention.

@nl

P1433

Q37497555-3DC352F6-EF06-4168-8D82-E8E9C12A7073

P1476

Q37497555-C831E5C0-D031-4AB4-B2A4-29F1F5DF8B8C

P2093

Q37497555-29894C54-D2AD-47A5-9187-09A6B07809FF

Q37497555-398FE6AC-1E7F-4A8F-B634-B9DD21A38991

Q37497555-4596D2F2-94BC-4ABC-A22A-BD082D682EE8

Q37497555-4F087AB7-21A6-4EA5-9A74-5D2A889A0D92

Q37497555-5A10F75B-3E82-46F6-B46D-4DFFEF58401E

Q37497555-5A7A438E-5A16-4795-897B-4169B7B50BF2

Q37497555-73AD24B1-9152-465B-8B3D-E77684D2F3A8

Q37497555-7AEA78E8-143C-4157-A92F-1A71C444DFFE

Q37497555-A9D7E2DC-C611-409E-BA76-51947EFAF571

Q37497555-C3854959-0DF5-40DE-885C-0BD95428D802

P275

Q37497555-19FC0914-CCB8-4334-9E89-D625A1A4DC45

P2860

Q37497555-025AFEDA-7B53-475F-9FB5-72A09CB296C1

Q37497555-0A1A900B-4783-4557-9DB7-1DEFB15356D8

Q37497555-10F38D86-4F3A-4B79-BD29-6103AD5724BA

Q37497555-112517AE-9FC0-4502-8632-1A8DB34EC009

Q37497555-1274C9D1-75B7-4313-B9ED-07037B8D9478

Q37497555-13F25276-9EFC-462C-A199-4144E64137A5

Q37497555-197DF39C-72AB-43EB-BC3B-913937903221

Q37497555-1D9C0B8B-55FA-4D32-9EEF-E09B6FF00A93

Q37497555-1DACC5CB-810C-4443-AC8B-BAD379A9B606

Q37497555-21ABA2D2-5D0A-4867-85B7-0884AF2F11E9

P304

Q37497555-49240FE2-57E2-4A6E-8C73-9B87AA3D3A50

P31

Q37497555-D069CE50-2AD8-4627-AA52-282313639A15

P356

Q37497555-8C408A20-EF38-4FD1-BA33-4EC923DB07FD

P433

Q37497555-708F15D9-E9EB-46A3-B5CB-E5DEEC87453D

P478

Q37497555-2673DFFC-2BDB-4088-BFDD-9F1F6C3F1C8C

P50

Q37497555-BD505A72-904E-4380-8200-4D72BBB74081

P577

Q37497555-81717B8B-3AAD-4E0E-A44E-B70594DFE64E

P5875

Q37497555-6B71918F-7C6A-4EF0-8BB4-5250FA5C7E62

P698

Q37497555-CA1D6963-7673-416C-AFFB-26CED52B4707

P921

Q37497555-81DFFF8A-E61F-40A7-9EC3-70E493721721

P932

Q37497555-9054C878-907C-49AA-AEAB-9C93A387B3EB

P356

P1433

European Heart Journal

P1476

Expert position paper on the r ...... utaneous coronary intervention

@en

P2093

András Komócsi

http://www.w3.org/2001/XMLSchema#string

Dietmar Trenk

http://www.w3.org/2001/XMLSchema#string

Dietrich Gulba

http://www.w3.org/2001/XMLSchema#string

Dirk Sibbing

http://www.w3.org/2001/XMLSchema#string

Dániel Aradi

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Collet

http://www.w3.org/2001/XMLSchema#string

Kurt Huber

http://www.w3.org/2001/XMLSchema#string

Laurent Bonello

http://www.w3.org/2001/XMLSchema#string

Róbert Gábor Kiss

http://www.w3.org/2001/XMLSchema#string

Steen Husted

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 3.0 Unported

P2860

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

Laboratory detection of 'aspirin resistance': what test should we use (if any)?

Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

P304

209-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHT375

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Robert F. Storey

P577

2013-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257073669

http://www.w3.org/2001/XMLSchema#string

P698

24067509

http://www.w3.org/2001/XMLSchema#string

P921

P932

3896861

http://www.w3.org/2001/XMLSchema#string